BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 10842610)

  • 1. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin.
    Quaranta A; Scaringi A; Aloidi A; Quaranta N; Salonna I
    Acta Otolaryngol; 2001 Apr; 121(3):387-92. PubMed ID: 11425206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vestibular nerve section in a child with intractable Menière's disease.
    See GB; Mahmud MR; Zurin AA; Putra SH; Saim LB
    Int J Pediatr Otorhinolaryngol; 2002 May; 64(1):61-4. PubMed ID: 12020915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin for Ménière's disease.
    Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
    Wang XY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
    Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
    Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Middle ear gentamicin-soaked pledgets in the treatment of Ménière's disease.
    MacKeith SA; Whiteside OJ; Mawby T; Bottrill ID
    Otol Neurotol; 2014 Feb; 35(2):305-9. PubMed ID: 24448291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS; Poe DS
    Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.